Assyro AI

FDA Orange Book · active-ingredient family

Tolazamide

Tolazamide is approved as 2 brand and 29 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:TOLINASE · NDA 015500

2

Brand (NDA)

29

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
TOLINASERLD×3PHARMACIA AND UPJOHNNDA 015500Approved Prior to Jan 1, 1982
TOLAZAMIDE×3COSETTENDA 018894Nov 02, 1984

Generic (ANDA) products (29)

ProductApplicantApplicationTEApproved
TOLAZAMIDEUSL PHARMAANDA 071355Jan 11, 1988
TOLAZAMIDECHARTWELL RXANDA 071633Dec 09, 1987
TOLAZAMIDESUN PHARM INDUSTRIESANDA 071357Jul 16, 1987
TOLAZAMIDESUN PHARM INDUSTRIESANDA 071358Jul 16, 1987
TOLAZAMIDESUN PHARM INDUSTRIESANDA 071359Jul 16, 1987
TOLAZAMIDEINTERPHARMANDA 071270Sep 23, 1986
TOLAZAMIDEINTERPHARMANDA 071271Sep 23, 1986
TOLAZAMIDEWATSON LABSANDA 070242Aug 01, 1986
TOLAZAMIDEWATSON LABSANDA 070243Aug 01, 1986
TOLAZAMIDEWATSON LABSANDA 070244Aug 01, 1986
TOLAZAMIDESUPERPHARMANDA 070763Jun 16, 1986
TOLAZAMIDESUPERPHARMANDA 070764Jun 16, 1986
TOLAZAMIDEUSL PHARMAANDA 070168Apr 02, 1986
TOLAZAMIDEUSL PHARMAANDA 070169Apr 02, 1986
TOLAZAMIDECHARTWELL RXANDA 070289Mar 13, 1986
TOLAZAMIDECHARTWELL RXANDA 070290Mar 13, 1986
TOLAZAMIDEBARRANDA 070162Jan 14, 1986
TOLAZAMIDEBARRANDA 070163Jan 14, 1986
TOLAZAMIDEBARRANDA 070164Jan 14, 1986
TOLAZAMIDEDURAMED PHARMS BARRANDA 070165Jan 10, 1986
TOLAZAMIDEDURAMED PHARMS BARRANDA 070166Jan 10, 1986
TOLAZAMIDEDURAMED PHARMS BARRANDA 070167Jan 10, 1986
TOLAZAMIDEWATSON LABSANDA 070513Jan 09, 1986
TOLAZAMIDEWATSON LABSANDA 070514Jan 09, 1986
TOLAZAMIDEWATSON LABSANDA 070515Jan 09, 1986
TOLAZAMIDEPAR PHARMANDA 070159Jan 06, 1986
TOLAZAMIDEPAR PHARMANDA 070160Jan 06, 1986
TOLAZAMIDEPAR PHARMANDA 070161Jan 06, 1986
TOLAZAMIDE×2NATCOANDA 070259Jan 02, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Tolazamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.